Barr Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript

  • download
  • Print
  • Recommend
  • 0

2008-05-09 13:25:11.0

Tags: Barr Pharmaceuticals Inc.

Question-and-Answer Session

Thank you. [Operator Instructions]. Our first question will come from the line of Gregg Gilbert of Merrill Lynch. Please go ahead.

Gregg Gilbert - Merrill Lynch

Thanks. Good morning.

Bruce L. Downey, Esq - Chairman and Chief Executive Officer

Good morning, Gregg.

Gregg Gilbert - Merrill Lynch

One two-part question on OCs. I was under the impression that the Barr and Watson sort of swap of customers did not result in a material share change. Is that correct? And has pricing been affected on a go forward basis? And secondly, Bill, can you quantify Yasmin's contribution to sales and EPS for '08? Thanks.

Bruce L. Downey, Esq - Chairman and Chief Executive Officer

I'll take the question, Gregg. It's Bruce. There was a switch of two customers that resulted in, I would say, a slight net market share loss to us. The customer we acquired was not as large as the customer we lost, although both were major customers, and that explains, I think, the difference between the 12% and... most of the difference between the 12% and 15% we estimated for the decline versus the 17% or 18% that we saw. And there was some fall-out in terms of pricing, although that stabilized and I think the market is stable right now. We have not quantified the Yasmin contribution as we don't normally do for any individual generic product and we're not going to start with Yasmin.

Gregg Gilbert - Merrill Lynch

Can you at least tell us why you're calling it a date certain launch, then?

Bruce L. Downey, Esq - Chairman and Chief Executive Officer

Because we're... a date certain, we're targeting July 1. It could be the last part of June, it could be the first part of July, because that's when we expect to launch the product.

Gregg Gilbert - Merrill Lynch

Thank you.

Operator

Thank you. And our next question will come from the line of Adam Greene of J.P. Morgan.

Adam Greene - J.P. Morgan

Thanks, good morning.

Bruce L. Downey, Esq - Chairman and Chief Executive Officer

Hi, Adam.

Adam Greene - J.P. Morgan

Hi. Following up on that question too, what are the remaining issues on Yasmin? Also, does the guidance... the revenue guidance include any contribution from YAZ or new brands? And then how should we think about the revenue progression for the rest of the year?

Bruce L. Downey, Esq - Chairman and Chief Executive Officer

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)